Fertility after ectopic pregnancy (EP) was investigated in a non-selected population taking into account intrauterine device (IUD) use at the time of the EP. Between January 1992 and June 1996, 647 women listed in the EP register of Auvergne (France) were followed up. The analysis included only the 328 women who were seeking to become pregnant: 23 women using IUD at the time of the index EP (IUD users) and 305 IUD non-users. Among IUD users, there was no recurrence of EP, and the 1 year cumulative rate was 87% [95% confidence interval (CI): 73-100%] for intrauterine pregnancies and 86% (95% CI: 72-100%) for deliveries. Among IUD non-users, the 2 year cumulative rate for recurrence of EP was 28% (95% CI: 17-39%), and the 1 year cumulative rates were 60% (95% CI: 53-66%) for intrauterine pregnancies and 44% (95% CI: 38-56%) for deliveries. The adjusted intrauterine pregnancy rate of IUD users was not significantly different from that of IUD non-users. However, IUD non-users had more miscarriages, so their delivery rate was lower.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/humrep/15.5.1173 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review.
Front Glob Womens Health
November 2024
WHO Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Background: Contraceptives play a crucial role in women's reproductive health, their hormonal components may be linked to cancer risks, specifically breast, and gynecological cancers. Given the high usage rates of hormonal contraceptives, it is vital to systematically evaluate their potential impact on cancer outcomes, especially among women with a family history of gynecological cancers.
Objectives: This study aims to evaluate the evidence on the association between modern contraceptive use and the risk of breast and reproductive cancers (ovarian, endometrial, and cervical cancer) among women of reproductive age, to inform healthcare providers, women, and program managers about cancer outcomes related to contraceptive use.
[Risks of urogenital infections and expulsion associated with the combination of an IUD and a menstrual cup].
Gynecol Obstet Fertil Senol
December 2024
Université Côte d'Azur (UCA), Rétines, Healthy, département d'Enseignement et de Recherche en Médecine Générale (DERMG), 28, avenue de Valombrose, 06107 Nice cedex 2, France.
Objectives: The increase in intrauterine devices (IUDs) contraception, and the growing use of reusables menstrual hygiene products such as the menstrual cup, necessitates an assessment of the implications of their co-use. The objectives are to assess whether women with IUDs who use menstrual cups have an increased risk of IUD expulsion and/or a change in the risk of upper and lower urogenital tract infections compared to women who use other menstrual hygiene products.
Method: An observational, prospective, multicenter study was conducted in France between 2020 and 2023.
Moderate associations between the use of levonorgestrel-releasing intrauterine device and metabolomics profile.
J Clin Endocrinol Metab
May 2024
Department of Public Health, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Context: Use of levonorgestrel-releasing intrauterine device (LNG-IUD) has become common irrespective of age and parity. To date, only a few studies have examined its possible metabolic changes and large-scale biomarker profiles in detail and in a longitudinal design.
Objective: To apply the metabolomics technique to examine the metabolic profile associated with the use of LNG-IUD both in a cross-sectional and in a longitudinal design.
Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial.
Contraception
June 2024
Contraceptive Development Program, Division of Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, USA.
Objective: To evaluate menstrual cup use and intrauterine device (IUD) expulsion.
Study Design: We performed a secondary analysis of a 3-year contraceptive efficacy trial comparing two copper 380 mm IUDs. Investigators randomized participants approximately 1:4 to the TCu380A or NTCu380-Mini IUD.
Hormonal intrauterine devices and heat exchange during exercise.
J Physiol
March 2024
Human and Environmental Physiology Research Unit, School of Human Kinetics, University of Ottawa, Ottawa, Ontario, Canada.
Synthetic progestins in oral contraceptives are thought to blunt heat dissipation by reducing skin blood flow and sweating. However, whether progestin-releasing intrauterine devices (IUDs) modulate heat loss during exercise-heat stress is unknown. We used direct calorimetry to measure whole-body total (dry + evaporative) heat loss in young, physically active women (mean (SD); aged 24 (4) years, 39.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!